Search

Your search keyword '"Pugh, Trevor J."' showing total 1,162 results

Search Constraints

Start Over You searched for: Author "Pugh, Trevor J." Remove constraint Author: "Pugh, Trevor J."
1,162 results on '"Pugh, Trevor J."'

Search Results

52. PRMT5 inhibition disrupts splicing and stemness in glioblastoma

53. Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab

54. Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

56. Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

57. Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panel

58. Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA

59. Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy

60. Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

61. Supplementary Figure S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

62. Data from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

63. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal

65. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer

66. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.

68. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.

69. Characterizing Risk Factors for Hospitalization and Clinical Characteristics in a Cohort of COVID-19 Patients Enrolled in the GENCOV Study

70. Identification of intratumoral and peripheral T-cell receptor (TCR) repertoire features associated with acquired (Ar) and primary (Pr) resistance to immune checkpoint inhibitors (ICI).

72. Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

73. Wnt activation as a therapeutic strategy in medulloblastoma

75. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer

77. Sensitive tumour detection and classification using plasma cell-free DNA methylomes

78. Supplementary Data S3 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

79. FIGURE 2 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

80. FIGURE 3 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

81. TABLE 1 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

82. TABLE 2 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

83. FIGURE 1 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

84. FIGURE 5 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

85. FIGURE 4 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

86. Supplementary Figures S1-S12 from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

87. Data from Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

88. Table TS6 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

89. Data from AACR Project GENIE: 100,000 Cases and Beyond

90. Figure S1 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

91. Supplementary Table from AACR Project GENIE: 100,000 Cases and Beyond

92. Supplementary Figure from AACR Project GENIE: 100,000 Cases and Beyond

93. Data from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

94. Abstract 4256: cBioPortal for Cancer Genomics

95. Data from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function

96. Abstract 6667: Pan-cancer assessment of tumour and peripheral T-cell receptor repertoire dynamics in patients treated with immune checkpoint inhibitors

97. Supplementary Figures and Tables from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function

98. Supplementary Table from Mutations in Noncoding Cis-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer

99. Data from AACR Project GENIE: Powering Precision Medicine through an International Consortium

100. Data from Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition

Catalog

Books, media, physical & digital resources